ATH-063
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ATH-063, covering 2024-05-03 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]